Stifel Financial Corp boosted its holdings in Icon Plc (NASDAQ:ICLR) by 2.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,545 shares of the medical research company’s stock after acquiring an additional 763 shares during the quarter. Stifel Financial Corp owned about 0.07% of Icon worth $4,160,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the business. Westfield Capital Management Co. LP raised its position in Icon by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 869,018 shares of the medical research company’s stock worth $98,964,000 after acquiring an additional 94,345 shares in the last quarter. Strategic Global Advisors LLC raised its position in Icon by 2.3% in the third quarter. Strategic Global Advisors LLC now owns 83,464 shares of the medical research company’s stock worth $9,505,000 after acquiring an additional 1,890 shares in the last quarter. Schwab Charles Investment Management Inc. raised its position in Icon by 9.4% in the third quarter. Schwab Charles Investment Management Inc. now owns 18,291 shares of the medical research company’s stock worth $2,083,000 after acquiring an additional 1,578 shares in the last quarter. Wells Fargo & Company MN raised its position in Icon by 1.3% in the third quarter. Wells Fargo & Company MN now owns 1,051,835 shares of the medical research company’s stock worth $119,782,000 after acquiring an additional 13,036 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its position in Icon by 11.5% in the third quarter. JPMorgan Chase & Co. now owns 42,043 shares of the medical research company’s stock worth $4,697,000 after acquiring an additional 4,320 shares in the last quarter. Hedge funds and other institutional investors own 89.95% of the company’s stock.

Icon Plc (NASDAQ ICLR) opened at $114.00 on Monday. The firm has a market capitalization of $6,160.00, a PE ratio of 21.88, a P/E/G ratio of 1.76 and a beta of 0.61. Icon Plc has a 12 month low of $73.76 and a 12 month high of $124.48. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.90 and a quick ratio of 1.90.

Icon (NASDAQ:ICLR) last released its earnings results on Thursday, October 26th. The medical research company reported $1.35 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.32 by $0.03. Icon had a return on equity of 28.42% and a net margin of 16.37%. The company had revenue of $440.30 million for the quarter, compared to analysts’ expectations of $438.09 million. During the same quarter in the previous year, the business posted $1.19 EPS. The business’s revenue for the quarter was up 4.8% on a year-over-year basis. analysts expect that Icon Plc will post 5.37 earnings per share for the current fiscal year.

ICLR has been the topic of a number of analyst reports. KeyCorp reissued an “overweight” rating and issued a $125.00 price target (up previously from $115.00) on shares of Icon in a research note on Monday, November 13th. They noted that the move was a valuation call. Zacks Investment Research cut Icon from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. SunTrust Banks reissued a “buy” rating and issued a $138.00 price target on shares of Icon in a research note on Sunday, October 29th. Barclays lifted their price target on Icon from $108.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Friday, October 27th. Finally, Credit Suisse Group reissued an “outperform” rating and issued a $120.00 price target (up previously from $105.00) on shares of Icon in a research note on Monday, October 16th. Four investment analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the company. Icon has a consensus rating of “Buy” and an average price target of $121.00.

ILLEGAL ACTIVITY WARNING: This report was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/stifel-financial-corp-raises-holdings-in-icon-plc-iclr/1770574.html.

Icon Company Profile

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.

Want to see what other hedge funds are holding ICLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR).

Institutional Ownership by Quarter for Icon (NASDAQ:ICLR)

Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.